Mineralys Therapeutics Inc. (MLYS)

Market is closed

Hedge Fund Popularity

13F filing is ongoing

Hedge Fund Holdings
Filing Period:
Last update:
No. Hedge Fund Shares Value Activity % Port
1.
RA Capital Management

Peter Kolchinsky

7,692,750 $208,396,598 +6% 2.21%
2.
Samsara BioCapital

Srini Akkaraju And Michael Dybbs

5,871,018 $159,045,878 15.45%
3.
Caligan Partners

David Johnson

2,772,654 $75,111,197 5%
4. 2,232,040 $60,465,964 +31% 2.64%
5.
OrbiMed Advisors

Samuel Isaly

2,052,900 $55,613,061 +110% 1.1%
Insider Trading: Purchases See All
Insider Price Amount Total Value Remaining Holdings Date Form 4
$24.16 58,300 $1,408,528.00 5,825,521 2026-03-30 Filing
$23.67 310,700 $7,354,269.00 5,767,221 2026-03-27 Filing
$25.50 588,235 $14,999,992.50 588,235 2025-09-04 Filing
$25.50 1,176,470 $29,999,985.00 5,456,521 2025-09-04 Filing
$13.50 259,259 $3,499,996.50 8,903,838 2025-03-13 Filing
Insider Trading: Sales See All
Insider Price Amount Total Value Remaining Holdings Date Form 4
$27.55 417 $11,488.35 63,443 2026-05-18 Filing
$28.58 14,056 $401,789.35 63,443 2026-05-13 Filing
$29.36 6,348 $186,348.08 69,792 2026-05-12 Filing
$29.71 2,171 $64,500.41 69,792 2026-05-11 Filing
$31.33 416 $13,033.28 69,792 2026-04-17 Filing
Institutional Investors' Holdings
Filing Period:
No. Name Shares Value % Port
1. 7,903,838 $214,114,971 92.81%
2. 4,861,104 $131,687,318 0.01%
3. 4,481,582 $121,406,057 0%
4. 3,359,068 $90,997,151 0.02%
5. 2,935,940 $79,534,615 0%
News See All